InvestmentJun 22, 2026, 06:07 AM
CervoMed Announces $10M Registered Direct Offering
AI Summary
CervoMed Inc. announced a registered direct offering of 2,500,000 shares of its common stock at a purchase price of $4.00 per share, aiming to raise $10.0 million in gross proceeds. H.C. Wainwright & Co. is acting as the exclusive placement agent, receiving a 6.0% cash fee and warrants. The company intends to use the net proceeds for working capital and general corporate purposes, with the closing expected around June 22, 2026.
Key Highlights
- CervoMed Inc. entered into a Securities Purchase Agreement for a registered direct offering.
- The company will issue and sell 2,500,000 shares of common stock at $4.00 per share.
- The offering is expected to generate aggregate gross proceeds of $10.0 million.
- H.C. Wainwright & Co. will serve as the exclusive placement agent, receiving a 6.0% cash fee.
- Wainwright will also receive warrants to purchase Common Stock equal to 6.0% of shares offered.
- The Placement Agent Warrants will have an exercise price of $5.00 per share.
- Net proceeds will be used for working capital and general corporate purposes.
- The offering is expected to close on or about June 22, 2026.
Price Impact
More from CRVO